Trials / Sponsors / Thomas Martin, MD
Thomas Martin, MD
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma Multiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | 2026-02-28 |
| Active Not Recruiting | Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma Refractory Multiple Myeloma, Relapsed Multiple Myeloma | Phase 1 | 2021-10-18 |
| Withdrawn | Rapid-infusion Isatuximab in Relapsed/Refractory Multiple Myeloma Relapsed Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | 2021-05-28 |
| Active Not Recruiting | Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple M Multiple Myeloma | Phase 1 | 2015-01-21 |